Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Sep;59(5):456-9.
doi: 10.4103/0019-5154.139872.

Topical steroid-damaged skin

Anil Abraham  1 , Gillian Roga  1
Affiliations

Topical steroid-damaged skin

Anil Abraham et al. Indian J Dermatol. 2014 Sep.

Abstract

Topical steroids, commonly used for a wide range of skin disorders, are associated with side effects both systemic and cutaneous. This article aims at bringing awareness among practitioners, about the cutaneous side effects of easily available, over the counter, topical steroids. This makes it important for us as dermatologists to weigh the usefulness of topical steroids versus their side effects, and to make an informed decision regarding their use in each individual based on other factors such as age, site involved and type of skin disorder.

Keywords: Cutaneous; adverse; steroids.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: Nil.

Figures

Figure 1
Figure 1
Atrophy: Wrinkling and thinning of skin 4 weeks after irregular use of Mometasone
Figure 2
Figure 2
Topical steroid - dependent face. Used as fairness cream for 2 months
Figure 3
Figure 3
Tinea incognito and broad striae on axilla
Figure 4
Figure 4
Striae due to topical steroid applied for 3 weeks for atopic dermatitis
See this image and copyright information in PMC

References

    1. Hengge UR, Ruzicka T, Schwartz RA, Cork MJ. Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol. 2006;54:1–18. - PubMed
    1. Brazzini B, Pimpinelli N. New and established topical corticosteroids in dermatology: Clinical pharmacology and therapeutic use. Am J Clin Dermatol. 2002;3:47–58. - PubMed
    1. Rapaport MJ, Lebwohl M. Corticosteroid addiction and withdrawal in the atopic: The red burning skin syndrome. Clin Dermatol. 2003;21:201–14. - PubMed
    1. Schoepe S, Schäcke H, May E, Asadullah K. Glucocorticoid therapy-induced skin atrophy. Exp Dermatol. 2006;15:406–20. - PubMed
    1. Bhat YJ, Manzoor S, Qayoom S. Steroid-induced rosacea: A clinical study of 200 patients. Indian J Dermatol. 2011;56:30–2. - PMC - PubMed